A listing of none medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This study aims to evaluate user experiences in commercial ESCAPE rooms to determine design opportunities for an ESCAPE room targeted for Rehabilitation after traumatic and non-traumatic brain injury. We will investigate older versus younger as well as healthy versus impaired user experiences in commercial ESCAPE room (survey) and 2) will …
To extend the geographic reach of clinicians, from urban hospitals to distant clinics, and to increase the objectivity of diagnostics, when applied to pediatric patients with upper extremity impairments, we propose a series of tests to validate the need and methods for the Lil'Flo robotic system. Lil'Flo is comprised of …
This study is being done to learn more about the safety of the study drug, AVID200, and to find out more about the effects of different study drug doses in people with scleroderma. AVID200 is referred to as an investigational drug because it is in the early stages of development …
This study is to learn more about social processes on a behavioral and brain level in new mothers. If you are eligible, there are three in person visits, one consisting of an fMRI scan. MRI uses magnetic fields to take pictures of the brain. MRI does not use X-rays and …
The main purpose of this study is to understand how well giant cell arteritis (also known as temporal arteritis; GCA) responds to an investigational drug called upadacitinib. Upadacitinib is being tested to find out if it is safe and effective in treating GCA. An investigational drug is one that is …
The research study is being conducted to see how well the investigational drug, Nefecon, works for the treatment of your kidney disease and more specific for patients with "primary immunoglobulin A nephropathy," called IgAN.
The PATCH trial tests hydroxychloroquine as a treatment in patients with COVID-19 and a preventative medication in health care workers at high risk of contracting COVID-19.
A double-blind placebo controlled trial of high dose hydroxychloroquine (HCQ) as a treatment for COVID-19 positive patients who are quarantined at home
The purpose of this research is to test an experimental drug CVL-562 as a possible treatment for early-course schizophrenia, schizoaffective disorder or related psychotic disorder.This study will test whether CVL-562 can help thinking and memory in people with schizophrenia.